CD96 and neoplasm: CD96 represents a new target for immune checkpoint receptors, known to either enhance or suppress NK cell activation, thus influencing the adhesion and spread of tumor cells.[25] Moreover, CD96 was reported to inhibit NK cell-induced cytokine responses and control cytokine release in Th9 cells.